Published Online: Friday, December 1, 2006

Citing concerns that importation of prescription drugs from Canada and other countries "may result in more counterfeit and unsafe products entering this nation's drug supply system," the Generic Pharmaceutical Association (GPhA) voiced strenuous objections to the sale of drugs "that have not been under the continuous supervision of the FDA." Like their counterparts in the brand name drug industry, GPhA leaders also expressed opposition to pharmaceutical price controls, noting that "timely competition is the key to affordability" of medications. "Importation is a means to importing price controls and is contrary to supporting robust drug research and development," the generic association maintained.

"Instead of unwisely attempting to reduce high prescription drug costs through unregulated foreign imports, American consumers can have safe and affordable prescription drugs through greater utilization of FDAapproved and regulated generic drugs and expanded prescription drug coverage," GPhA said. "Americans seeking savings won't always find them across the border—on average, generics are less expensive in the United States than in Canada and do not put the quality of US health care at risk."

Latest Articles
Beverly Schaefer, RPh, of Katterman's Sand Point Pharmacy in Seattle, Washington, shares some fun tips on how to encourage patients who travel to come to your pharmacy for supplies.
Donnie Calhoun, RPh, PD, National Community Pharmacists Association (NCPA) Foundation vice president, discusses how pharmacists can prepare themselves and their business before, during, and after a disaster.
Ken Whittemore Jr, Surescript's senior vice president of professional and regulatory affairs, talks about some new transactions available that can help pharmacists.
In case you got caught up in the Thanksgiving holiday rush, here are the top trending stories you may have missed in November:
Latest Issues